In monolayer cultures of P19 EC cells treated with both
Introduction
During development, bone morphogenic protein (BMP)-4, a member of the TGF-b family, induces apoptosis of cells in the interdigits 1 and of neural crest-derived cells located in the rhombomeres.
2,3 Disruption of BMP-2 and -4 signaling by a dominant-negative BMP type I receptor mutation prevents interdigital apoptosis. 4 Similarly, mutant mice with a targeted deletion of the retinoic acid receptor (RAR) a gene and one or both alleles of the RAR g gene show a marked decrease in the number of apoptotic cells in the interdigital necrotic zones. 5 Thus, both retinoic acid and BMP signals are involved in apoptosis of cells in the interdigits.
All-trans retinoic acid (RA) induces neuroectodermal differentiation in aggregated P19 EC cells and mesoderm and endoderm differentiation in P19 EC cell monolayers. 6 During RA-induced neuronal differentiation of P19 EC cells, many cells undergo cell death with the hallmarks of apoptosis, including cytoplasmic contraction and DNA fragmentation. 7, 8 BMP-4 alone and RA alone cause slight induction of apoptosis of P19 EC cells cultured as monolayers, but BMP-4 and RA together induce severe apoptosis of P19 EC cells. 9, 10 RA/BMP-4-induced apoptosis is mediated through activation of RAR a and g in P19 EC cells. 10 However, little is known about the molecular mechanism by which BMP-4 and RA synergistically induce apoptosis.
Genetic studies of apoptosis in Caenorhabditis elegans have identified genes involved in apoptosis: ced-9 prevents apoptosis 11 and ced-3 and ced-4 promote apoptosis. 12, 13 In mammals, caspases, which are homologues of Ced-3, are involved in various types of cell death. 14, 15 Caspases are activated by a cascade of sequential enzymatic cleavages by other members of this family. 16 During apoptosis, caspase-3, which is the last enzyme in this cascade, is activated by processing of procaspase-3 (p32) into its active forms (p20/17 and p12). 17 Caspase-9, which is activated through its association with Apaf-1, a homologue of Ced-4 that also binds cytochrome c, 18 is autoprocessed into its active form, and it activates caspase-3. apoptosis protein (XIAP), 25 which can directly inhibit caspase activity, 26 has been shown to bind TAB1, an activator of TAK1, and inhibit TAK1-induced apoptosis. 27 Furthermore, BMP-2-induced neuronal cell death is inhibited by wide range caspase inhibitor z-VAD. 28 In the present study, we demonstrate that BMP-4 and RA synergistically decrease XIAP in the cytosol of P19 EC cells cultured as monolayers and activate the caspase-9 to -3 apoptotic pathway.
Results
We used the anti-p20/17 antibody to examine immunohistochemically whether caspase-3 is activated when apoptosis is induced in P19 EC cells by RA-and/or BMP-4 treatment. In monolayer cultures of P19 EC cells treated for 24 h with RA and BMP-4 together, many non-adherent cells demonstrating cytoplasmic contraction, a hallmark of apoptosis, and many p20/17-positive cells were observed, but they were observed infrequently or not at all in the cultures incubated with RA or BMP-4 alone ( Figure 1) .
Consistent with the appearance of p20/17-positive cells, Ac-DEVD-MCA cleavage activity, which reflects activation of caspase-3, increased when cells were incubated with RA and BMP-4 together for 24 h (Figure 2A ). RA (1000 nM) alone induced caspase-3 activation slightly and BMP-4 (10 ng/ml) alone did not. DNA fragmentation was also induced by RA/BMP-4-treatment and corresponded to the increase in Ac-DEVD-MCA cleavage activity ( Figure 2B ).
We examined the caspases upstream of caspase-3 that are activated during apoptosis induced by RA/BMP-4-treatment. Caspase-9 is one of the enzymes upstream of caspase-3. The molecular weight of mouse caspase-9 predicted from the nucleotide sequence is 50 kDa (nucleotide sequences have been deposited into DDBJ, Accession No. ABO19600). Only two amino acids in the peptide of mouse caspase-9 differed from those of human caspase-9, which was used as antigen to generate anticaspase-9 (I16). When N-terminal FLAG-tagged (N-FLAG) mouse caspase-9 was transfected into COS cells, 50 kDa (p50) and 37 kDa (p37) bands were detected with both anti-FLAG and anti-caspase-9 ( Figure 3A) .
When N-FLAG mouse caspase-9 was transfected into P19 EC cells, Ac-DEVD-MCA activity increased in a timedependent manner ( Figure 3B ). p50 was detected with anticaspase-9 in untreated P19 EC cells, and 30 kDa (p30) bands as well as p50 bands were detected in P19 EC cells transfected with mouse caspase-9 ( Figure 3C ). However, no bands were detected with anti-FLAG because the Nterminal region of caspase-9 is cleaved off in P19 EC cells (Fujita, unpublished data) . Ac-DEVD-CHO (10 mM), which completely inhibited Ac-DEVD-MCA cleavage activity, did not inhibit the processing of caspase-9 (p50) into p30 in P19 EC cells ( Figure 3C ).
In addition to the activation of caspase-3, generation of p30 was also induced by RA/BMP-4-treatment, and it corresponded to the increase in Ac-DEVD-MCA cleavage activity ( Figure 4A ). Furthermore, Ac-DEVD-CHO (1 ± 20 mM) inhibited the DNA fragmentation induced by RA/ BMP-4 treatment but did not affect the processing of caspase-9 ( Figure 4B,C) . Thus, caspase-9 is upstream of caspase-3 in the apoptosis pathway induced by RA/BMP-4-treatment.
The synergistic effects of RA and BMP-4 on processing of caspase-9 were examined. RA (100 ± 1000 nM) slightly induced processing of caspase-9 and changed Ac-DEVD-MCA cleavage activity in monolayer cultures of P19 EC cells. BMP-4 (1 ng/ml) increased Ac-DEVD-MCA cleavage activity, processing of caspase-9, and DNA fragmentation of P19 EC cells treated with 1 ± 1000 nM RA ( Figure 5 ). RA (100 nM) in combination with BMP-4 (1 ng/ml) yielded the maximum effect on Ac-DEVD-MCA cleavage activity. BMP-4 (0.1 ± 5 ng/ml) alone did not induce processing of caspase-9, change Ac-DEVD-MCA cleavage activity, or induce DNA fragmentation in the monolayer cultures of P19 EC cells. BMP-4 (0.1 ± 5 ng/ml) enhanced these changes in a dose-dependent fashion in P19 EC cells treated with 1000 nM RA ( Figure 6 ). Thus, BMP-4 alone could not induce activation of caspase-9, but it enhanced the RAinduced activation of caspase-9 that led to the apoptosis of P19 EC cells.
Bcl-xL, a member of the Bcl-2 family that inhibits activation of caspase-3 through interaction with Apaf-1 and caspase-9, 29, 30 inhibited Ac-DEVD-MCA cleavage activity and DNA fragmentation in P19 EC cells treated with both RA (1000 nM) and BMP-4 (0.1 ± 5 ng/ml) ( Figure  7A ,B). Bcl-xL also inhibited processing of caspase-9 in cells treated with RA and BMP-4.
Cytochrome c released from mitochondria activates caspase-9 by association with Apaf-1 in the cytosol. 18 The levels of cytochrome c and other molecules, which regulate processing of caspase-9, were examined in the cytosol of non-adherent apoptotic cells and adherent living cells after RA/BMP-4-treatment. The non-adherent cells showed high levels of DNA fragmentation, whereas adherent cells did not ( Figure 8A ). Consistent with DNA fragmentation, Ac-DEVD-MCA cleavage activity in the cytosol of the non-adherent cells was approximately four times higher than that in the cytosol of all cells. Processing of caspase-9 was also preferentially stimulated in the cytosol of non-adherent cells but not in the cytosol of adherent cells ( Figure 8B ). However, Apaf-1 and cytochrome c levels in the cytosol of the non-adherent and adherent RA/BMP-4-treated cells matched those in the cytosol of untreated P19 EC cells. In contrast, XIAP was down-regulated in the cytosol of non-adherent cells but not in the cytosol of adherent cells. In the staurosporineinduced apoptotic cells, however, the level of cytochrome c increased in the cytosol, whereas the levels of XIAP and Apaf-1 did not change. 17 In the caspase cascade, caspase-9 is upstream of caspase-3;
31 ± 33 caspase-3 is not activated in caspase-9-deficient mice. However, caspase-3 also participates in a feedback amplification loop involving caspase-9, 33 and the activated caspase-3 cleaves caspase-9. During apoptosis of P19 EC cells induced by RA/BMP-4-treatment, the caspase-9 to -3 apoptotic pathway was activated ( Figures  3, 4) . Caspase-9 induced Ac-DEVD-MCA cleavage activity in P19 EC cells, whereas Ac-DEVD-CHO inhibited DNA fragmentation but not processing of caspase-9 induced by RA/BMP-4-treatment. It is unlikely that the caspase-3 to -9 feedback pathway is involved in RA/BMP-4-mediated apoptosis.
We do not exclude the possibility that other caspases upstream of caspase-3 are also activated by RA/BMP-4. However, we could not detect changes in caspase-1, -6, -7, and -8 activities in RA/BMP-4-treated cells using synthetic substrates for caspases (data not shown). Inhibitors of these caspases did not prevent apoptosis or Ac-DEVD-MCA cleavage activity induced by RA/BMP-4-treatment (data not shown). These results indicate that the caspase-9 to -3 pathway is the predominant pathway in the apoptosis of P19 EC cells induced by RA/BMP-4-treatment. Development of a specific inhibitor of autoprocessing of caspase-9 is currently underway for further analysis.
Cytochrome c release in the RA and BMP-4-treated apoptotic cells
Bcl-xL prevented processing of caspase-9 induced by RA/ BMP-4 treatment (Figure 7 ). At present, the only apoptotic pathway known to activate caspase-9 and to be regulated by Bcl-xL is the Apaf-1/cytochrome c-induced pathway. 29, 30 BclxL inhibits activation of caspase-9 through two possible mechanisms: by preventing release of cytochrome c from mitochondria or by forming a complex with Apaf-1 and caspase-9. However, unlike staurosporine, 34 RA/BMP-4 treatment did not increase cytochrome c levels even in the cytosol of non-adherent apoptotic cells with high caspase-9 processing activity and Ac-DEVD-MCA cleavage activity (Figure 8 ), suggesting that RA and BMP-4 signals activate caspase-9 without releasing cytochrome c from mitochondria. Recently, an alternative pathway that activates the caspase cascade was reported. RGD peptides directly activate caspases independent of the Apaf-1/cytochrome c apoptotic pathway. 35 RA and BMP-4 signals may activate caspase-9 through such an alternative pathway. However, reductions in mitochondria transmembrane potentials, which accompany early apoptosis in many situations, were detected in the RA and RA/BMP-4-treated cells as well as in staurosporinetreated cells by fluorescence of the cationic lipophilic dye CMTMRos 34 (Momoi, unpublished data). We do not exclude 
Down-regulation of XIAP in the RA and BMP-4-treated P19 EC cells
Neuronal apoptosis inhibitor protein (NIAP), a homologue of XIAP, which is a candidate gene for type I spinal muscular atrophy (SMA), has an anti-apoptotic effect on apoptosis induced by a variety of signals, and it contributes to the SMA phenotype when deficient or absent. 25 Very recently, XIAP has been shown to participate in the BMP signaling pathway as a positive regulator linking the BMP receptor and TAK1 and its activator, TAB. 27 Activation of the BMP receptor by ligand binding elicits signals that induce not only ventralization but also apoptosis in Xenopus embryos through TAK1 activation. 24 Overexpression of XIAP inhibits TAK1-induced apoptosis and promotes TAK1-induced ventralization, 27 suggesting that XIAP is a key molecule regulating the apoptosis signals in the BMP receptor-TAK1 pathway. The level of XIAP may determine BMP-4-receptor-signal stimulation of the apoptotic pathway and the other signal pathways. The prominent decrease in the level of XIAP in the cytosol of the RA/BMP-4-treated apoptotic cells (Figure 8 ) may explain their synergistic effect on the activation of caspase-9. A small amount of caspase-9 activated by RA via undetectable levels of released cytochrome c or an unknown apoptotic pathway may induce the processing of a large amount of caspase-9 in Molecular mechanism of RA and BMP-4 inducing synergistic effect on the activation of caspase-9
The reason why BMP-4 alone cannot induce apoptosis and always requires RA synergistically is unclear. One possible explanation is that RA makes P19 EC cells competent to respond to BMP-4 signals or vice versa. BMP-4 receptors type I and type II were upregulated 2-fold in RA-treated cells (data not shown), suggesting that the upregulation of BMP-4 signals induces the synergistic effect of RA and BMP-4 on activation of caspase-9 and apoptosis.
Msx-2, homeobox-containing gene, is one of the possible downstream targets of BMP-4-induced apoptosis signals. Msx-2 is expressed in the same regions in which BMP-4 induces cell death. Disruption of BMP-2 and -4 signaling by a dominant-negative BMP type I receptor prevents interdigital apoptosis and decreases of the Msx-2 expression. 4 Constitutive ectopic expression of Msx-2 in P19 EC cells markedly increases apoptosis induced upon aggregation. 36 However, Msx-2 is not significantly upregulated by RA/BMP-4-treatment (Momoi, unpublished data).
Finally, we do not exclude the possibility that SMADs, the central effector molecules for BMP receptor signals, 37 are involved in RA/BMP-4-induced apoptosis of P19 EC cells, since a dominant-negative mutation of SMAD inhibits processing of caspase-9 induced RA/BMP-4-treatment (Momoi, unpublished data). A further study of the molecular mechanism by which the combination of BMP-4 and RA activates caspase-9 and reduces the level of XAIP in the cytosol is currently underway.
Materials and Methods
Cell culture Ac-DEVD-MCA cleavage activity P19 EC cells were incubated with RA and/or BMP-4 for various periods. Ac-DEVD-MCA cleavage activity was measured as described previously. 38 After incubation, cells were washed twice with PBS, and the cell pellets were lysed in PBS containing 0.2% Triton X-100 on ice for 10 min. Cells were then centrifuged at 10 0006g for 5 min. To measure caspase-3-like activity the cell extracts (50 mg protein) were incubated with 10 mM Ac-DEVD-MCA (Peptide Institute, Osaka, Japan), a synthetic peptide of the cleavage site of poly-ADP ribose polymerase, in incubation buffer (50 mM Tris-HCl pH 7.5, 1 mM dithiothreitol) at 378C for 20 min. The reactions were stopped by the addition of 10% sodium dodecyl sulfate (SDS). Fluorescence intensity was measured at 380 nm for excitation and at 460 nm for emission.
Isolation of fragmented DNA
DNA isolation was performed according to Prigent et al, 39 with some modification. Cell pellets were lysed with 400 ml of lysis buffer (20 mM Tris-HCl, pH 7.4, 20 mM EDTA and 1% Triton X-100). Lysis was allowed to proceed on ice for 10 min, and the mixture was centrifuged for 10 min at 10 0006g. The supernatant was digested with 50 mg/ml RNase A at 378C for 1 h. This was followed by proteinase K (50 mg/ml) digestion at 378C for 1 h. After phenol-chloroform extraction, the DNA was precipitated by adding 2.5 vol of 100% ethanol and CH 3 COONa (0.3 M final concentration). DNAs were separated on 1.8% NuSieve agarose (FMC Bioproducts, Rockland, ME, USA) gels.
Transfection of caspase-9
A full-length mouse caspase-9 cDNA was obtained from a cDNA library of RA-treated P19 EC cells (Stratagene, La Jolla, CA, USA). The cDNA was inserted into the EcoRI site of the pcDEF3 expression vector and transfected into P19 EC cells by the calcium-phosphate method. 40 Eight hours after transfection in the presence or absence of Ac-DEVD-CHO (10 mM), the transfected P19 EC cells were washed with cell culture medium and cultured again in the presence or absence of Ac-DEVD-CHO (10 mM) for the indicated period.
P19 EC cells stably overexpressing Bcl-xL were obtained by transfection with pMKITNeo-bcl-xL and selection with G418 as described previously. 
Immunoblot analysis
Cells were lysed in PBS containing 0.2% Triton X-100. After centrifugation at 10 0006g for 10 min, the cell extracts (50 mg protein) were subjected to SDS-acrylamide gel (12%) electrophoresis. After transfer to nitrocellulose membranes, immunoreactivity was detected with anti-caspase-9 (I16), anti-XIAP, anti-Apaf-1 (MBL, Nagoya, Japan), and anti-cytochrome c (clone 7H8.2C2, Pharmingen, San Diego, CA, USA) antibodies and alkaline phosphataseconjugated goat anti-mouse or rabbit immunoglobulin (Promega, Madison, WI, USA).
Assay for cytochrome c in the cytosol
Cytosolic levels of cytochrome c were examined according to the method of Rosse et al. 42 P19 EC cells were treated with RA (1000 nM) and/or BMP-4 (1 ng/ml) for 24 h or staurosporine (1 mM) for 5 h and then cells were collected by centrifugation. Cells pellets were homogenized in 200 ml extraction buffer (10 mM HEPES buffer, pH 7.5, 0.25 M sucrose, 1 mg/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride), and the cytosol and membrane fractions including mitochondria were separated by centrifugation at 14 0006g for 15 min at 48C. Levels of cytochrome c were examined by immunoblot analysis as described above.
Immunocytochemical staining of activated caspase-3 RA and/or BMP-4-treated P19 EC cells were fixed with 2% paraformaldehyde for 15 min. They were then incubated with anti-p20/17 antibody, an antiserum specific against activated caspase-3, as described previously. 22, 43 Immunoreactivity was detected by peroxidase-conjugated avidin-biotin kit (Vectastain ABC kit, Vector Labs, Burlingame, CA, USA) and diaminobenzidine (DAB) (Sigma).
